SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-21-006164
Filing Date
2021-03-31
Accepted
2021-03-30 17:42:17
Documents
71
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K blcm-20201231.htm   iXBRL 10-K 1965988
2 EX-10.5B exhibit105b_2019equityince.htm EX-10.5B 349389
3 EX-21 bellicum-ex211subsidiaries.htm EX-21 2167
4 EX-23 bellicum-ex231consentofey2.htm EX-23 3923
5 EX-31.1 exh311certofceocfo2020q4.htm EX-31.1 9042
6 EX-32.1 exh321certceocfosox2020q4.htm EX-32.1 5625
  Complete submission text file 0001628280-21-006164.txt   9092513

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20201231.xsd EX-101.SCH 52494
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20201231_cal.xml EX-101.CAL 98259
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20201231_def.xml EX-101.DEF 299681
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20201231_lab.xml EX-101.LAB 752757
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20201231_pre.xml EX-101.PRE 500260
12 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20201231_htm.xml XML 1388316
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36783 | Film No.: 21788655
SIC: 2834 Pharmaceutical Preparations